Related articles
Join us at the Investment Company Showcase on 11 October
Biotechnology & Healthcare: a sector on the mend?
The investment companies set to benefit after rates peak
Related videos
Me and my trusts: Gavin Lumsden
Me and my trusts: Gavin Lumsden reveals what investment trusts he holds, and why.
Me and my trusts: Gavin Lumsden on what got him investing in investment trusts
Me and my trusts: Gavin Lumsden on why he prefers investment trusts to other funds.
Related industry news
Morning briefing: Preqin founder raises HgCapital stake to £94m; Saba lifts SEIT, SCP; Custodian Property Income holds “talks” with family offices; plus SST, BLND, LAND, SYNC
Valhalla Ventures, the holding company of Preqin founder Mark O’Hare and his wife Linda, raised its new position in HgCapital Trust (HGT) from 3.3% to...
How healthy is your portfolio?
Over six months have passed since Cherry Reynard wrote about the biotech and healthcare sector for us in this article – The biotech bust: a case study...
Morning briefing: Syncona writes down cancer fund by £16m; ICG Enterprise exits David Lloyd; plus CREI
Syncona (SYNC), the £608m life sciences fund seeking to return £250m of capital to compensate shareholders for its steep share price discount, suffere...
Syncona U-turns on wind down in favour of £250m cash return
The UK's only listed life sciences fund has scrapped plans to close, instead returning £250m before focusing on growth once again.
Investment company news brought to you by Citywire Financial Publishers Limited
and QuotedData by Marten & Co.
Data provided by Morningstar.
Company documents provided by FE fundinfo.